Astellas has confirmed that it will keep 90 of the 240 employees at OSI Pharmaceuticals' operations in Farmingdale, NY. "By providing OSI employees with more clarity regarding the plans for the integration and organizational decisions, we hope to minimize their uncertainty," Astellas says, as quoted by the Long Island Business News.
In July, the Japanese company said it was shuttering operations in Ardsley and Melville, NY, both of which it acquired in the $4 billion buyout of OSI Pharmaceuticals. Roughly 150 workers are employed at the sites, which will close by June 2011. Astellas still plans to close those facilities and the one located in Cedar Knolls, NJ, by the end of 2011, the Long Island Business News reports.
"While they're moving their Melville operations off the Island, there was a fear they were going to move their operations at the bio-science park off Long Island as well," Long Island Association President Kevin Law says. "The good news is they're keeping those jobs at Farmingdale, where they'll continue to have a biotech presence."
Law adds the Long Island Association, the Empire State Development Corp. and the bio-science park worked with Astellas to keep the jobs in Farmingdale.
- get more from the Long Island Business News